Co-Treatments of Edible Curcumin from Turmeric Rhizomes and Chemotherapeutic Drugs on Cytotoxicity and FLT3 Protein Expression in Leukemic Stem Cells

This study aims to enhance efficacy and reduce toxicity of the combination treatment of a drug and curcumin (Cur) on leukemic stem cell and leukemic cell lines, including KG-1a and KG-1 (FLT3(+) LSCs), EoL-1 (FLT3(+) LCs), and U937 (FLT3(−) LCs). The cytotoxicity of co-treatments of doxorubicin (Dox...

Descripción completa

Detalles Bibliográficos
Autores principales: Chueahongthong, Fah, Tima, Singkome, Chiampanichayakul, Sawitree, Berkland, Cory, Anuchapreeda, Songyot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510311/
https://www.ncbi.nlm.nih.gov/pubmed/34641328
http://dx.doi.org/10.3390/molecules26195785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510311/
https://www.ncbi.nlm.nih.gov/pubmed/34641328
http://dx.doi.org/10.3390/molecules26195785

Ejemplares similares